Massimo Gentile

100PUBLICATIONS
306CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Predictive and prognostic markersCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (100)

|Sep 28, 2026
Host Fitness: A Missing Dimension of Precision Medicine in Older Acute Myeloid Leukemia.

|Sep 04, 2026
Role of direct-acting antivirals in people with HIV-associated non-Hodgkin lymphoma and concomitant HCV infection: A study on behalf of the Fondazione Italiana Linfomi.

|Aug 26, 2026
Bispecific Antibodies for Acute Myeloid Leukemia: From Bone Marrow Immune Niche to Clinical Translation.

|Aug 18, 2026
Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.

|Aug 04, 2026
DRP1-mediated mitochondrial fragmentation is a druggable vulnerability in multiple myeloma.

|Jul 09, 2026
Bridging Randomized Trial Efficacy and Real-World Effectiveness in Multiple Myeloma: Integrating Clinical Trials and Real-World Evidence for Individualized Care.

Pageof 17

Frequent Collaborators

30 joint publications

Francesco Mendicino

14 joint publications

Fortunato Morabito

12 joint publications

Luca Laurenti

11 joint publications

Livio Trentin